Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis

Abstract Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the...

Full description

Bibliographic Details
Main Authors: Mingyue Ji, Yun Liu, Zhi Zuo, Cheng Xu, Li Lin, Yong Li
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Biology Direct
Subjects:
Online Access:https://doi.org/10.1186/s13062-022-00334-w
_version_ 1811285955057811456
author Mingyue Ji
Yun Liu
Zhi Zuo
Cheng Xu
Li Lin
Yong Li
author_facet Mingyue Ji
Yun Liu
Zhi Zuo
Cheng Xu
Li Lin
Yong Li
author_sort Mingyue Ji
collection DOAJ
description Abstract Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the oxidative stress and apoptosis was involved in the influence of AREG on cardiac hypertrophy. Angiotensin (Ang) II induced cardiac hypertrophy in mice and neonatal rat cardiomyocytes (NRCMs) or HL-1 cells in vitro. AREG expressions raised in the heart of mice. After AREG downregulation, the increases of Ang II induced cardiac weight and cardiomyocytes area were inhibited. Down-regulation of AREG could inhibit Ang II induced the increases of atrial natriuretic peptide, brain natriuretic peptide, beta-myosin heavy chain in the heart of mice, and NRCMs and HL-1 cells. The enhancement of oxidative stress in mice heart with Ang II treatment was alleviated by AREG knockdown. The raises of Ang II induced Bax and cleaved caspase3 in mice heart were inhibited by AREG downregulation. AREG downregulation reduced myocardial hypertrophy via inhibition of oxidative and apoptosis. AREG may be a target for future cardiac hypertrophy treatment.
first_indexed 2024-04-13T02:51:37Z
format Article
id doaj.art-cb58fe147f8f44f0a7aabda61f7ad92e
institution Directory Open Access Journal
issn 1745-6150
language English
last_indexed 2024-04-13T02:51:37Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Biology Direct
spelling doaj.art-cb58fe147f8f44f0a7aabda61f7ad92e2022-12-22T03:05:49ZengBMCBiology Direct1745-61502022-08-0117111010.1186/s13062-022-00334-wDownregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosisMingyue Ji0Yun Liu1Zhi Zuo2Cheng Xu3Li Lin4Yong Li5Department of Cardiology, Lianshui County People’s HospitalDepartment of Intensive Care Medicine, the First Affiliated Hospital of Nanjing Medical UniversityDepartment of Cardiology, the First Affiliated Hospital of Nanjing Medical UniversityDepartment of Cardiology, Lianshui County People’s HospitalDepartment of Cardiovascular Medicine, East Hospital, Tongji University School of MedicineDepartment of Cardiology, the First Affiliated Hospital of Nanjing Medical UniversityAbstract Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the oxidative stress and apoptosis was involved in the influence of AREG on cardiac hypertrophy. Angiotensin (Ang) II induced cardiac hypertrophy in mice and neonatal rat cardiomyocytes (NRCMs) or HL-1 cells in vitro. AREG expressions raised in the heart of mice. After AREG downregulation, the increases of Ang II induced cardiac weight and cardiomyocytes area were inhibited. Down-regulation of AREG could inhibit Ang II induced the increases of atrial natriuretic peptide, brain natriuretic peptide, beta-myosin heavy chain in the heart of mice, and NRCMs and HL-1 cells. The enhancement of oxidative stress in mice heart with Ang II treatment was alleviated by AREG knockdown. The raises of Ang II induced Bax and cleaved caspase3 in mice heart were inhibited by AREG downregulation. AREG downregulation reduced myocardial hypertrophy via inhibition of oxidative and apoptosis. AREG may be a target for future cardiac hypertrophy treatment.https://doi.org/10.1186/s13062-022-00334-wAmphiregulinCardiac hypertrophyOxidative stressApoptosis
spellingShingle Mingyue Ji
Yun Liu
Zhi Zuo
Cheng Xu
Li Lin
Yong Li
Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
Biology Direct
Amphiregulin
Cardiac hypertrophy
Oxidative stress
Apoptosis
title Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
title_full Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
title_fullStr Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
title_full_unstemmed Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
title_short Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
title_sort downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis
topic Amphiregulin
Cardiac hypertrophy
Oxidative stress
Apoptosis
url https://doi.org/10.1186/s13062-022-00334-w
work_keys_str_mv AT mingyueji downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis
AT yunliu downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis
AT zhizuo downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis
AT chengxu downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis
AT lilin downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis
AT yongli downregulationofamphiregulinimprovescardiachypertrophyviaattenuatingoxidativestressandapoptosis